Pharmaceutical Intermediates Market
Pharmaceutical Intermediates Market - By Application (Pharmaceutical Companies,Â Research Labs,Â Contract Manufacturing Organizations,Â Others) & Global Region - Market Size, Trends, Share & Forecast 2020-2025Request Sample Request Discount
Rising Production of APIs
Increasing production of active pharmaceutical ingredients is accelerating the demand for pharmaceutical intermediates. Further, increasing trend towards new high-tech therapeutics coupled with the development of innovative delivery systems and innovation in personalized medicine is believed to further emphasize the growing demand for the active pharmaceutical market. This bodes well for global pharmaceutical intermediates market. Due to the rise in the demand for quality APIs, there is growing investment in research & development for API production which will result in increased demand for pharmaceutical intermediates.
Launch of Innovative Pharmaceutical Intermediates
Pharmaceutical intermediates manufacturers are investing heavily in the development of new intermediates. The market is also expected to significantly benefit from this. In addition, patent expiry is also supposed to positively impact the growth of the global pharmaceutical intermediate market. Apart from this, continuous demand for new and innovative therapies are offering promising growth of pharmaceutical intermediates market over the forecast period.
Increasing Prevalence of Diseases
Rising prevalence of various infectious and chronic diseases is resulting in increased demand for pharmaceuticals which, in turn, is spearheading current and future growth of pharmaceutical intermediates market. According to the CDC (Centers for Disease Control and Prevention), there were around 16.8 million physician visits for infectious and parasitic diseases in the United States. Further, supportive government healthcare initiatives are believed to garner the growth of the market in the years ahead.
Barriers in Market
The pharmaceutical industry comprises of a large pool of small, medium & giant manufacturers of pharmaceutical intermediates. Apart from this, the number of contract manufacturing organizations are also increasing especially in the Asia Pacific region which has also increased market competition across the globe. Regulatory requirements are tightening and will likely continue to do so with a push for more transparency in the supply chain in the future. These increasing regulatory related issues have brought difficulties for pharmaceutical intermediate suppliers across the globe. The prices of intermediates are moving up as regulatory-related expenses such as fees related to the Generic Drug User Fee Act in the U.S. Are increasing. This unstable pricing trend is adversely affecting the supplying network of the intermediates. Most of the demand for pharmaceutical intermediate is largely derived from the demand for drug manufacturers' products. This factor subjects pharmaceutical intermediate manufacturers to uncertainties related to downturns in their customers.
The world pharmaceutical intermediates are segmented by end-user into four: pharmaceutical companies, research labs, contract manufacturing organizations, and others. With a market share of 76.4%, pharmaceutical companies market captured the major portion of the market. According to KDMI, in the end-user segment, the pharmaceuticals company market is expected to be the most attractive market in the global pharmaceutical intermediates market over the forecast period. Further, this market is projected to open new avenues for the market players and to be the most lucrative market over the forecast period. Apart from this, when compared with other segments, the research labs market is anticipated to attain the highest CAGR over the upcoming years i.e. 2020-2025.
In terms of geography, the pharmaceutical intermediates market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Pharmaceutical intermediates market in China was held at USD 6,685.1 Million in 2018 and is presenting a lucrative growth opportunity for industry players. At projected CAGR China will be one of the fastest growing pharmaceutical intermediates market in the years ahead.
The key players profiled in the report include Aceto, Eastar, BASF SE, Midas Pharma, A.R. Life Sciences Pvt. Ltd., Lianhetech and other major key players. These market players have adopted different business strategies, such as acquisition, product launch, merger, and partnership to stay competitive in the global market. Pharmaceutical intermediates companies are expanding their businesses in terms of product offering and regional markets. This expansion trend is benefiting manufacturers by allowing them to deliver more advanced one-stop solutions to their customers. For instance, AGC Inc. has recently expanded its facilities at its Chiba Plant that resulted in an approximately tenfold increase in the company’s GMP1-compliant synthetic pharmaceutical intermediate and active ingredient2 production capacity.
By End User
- Pharmaceutical Companies
- Research Labs
- Contract Manufacturing Organizations
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa
Custom Research Requirement? Questions to ask?Get in touch
Custom Research requirement.